Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · IEX Real-Time Price · USD
26.94
-0.31 (-1.14%)
At close: Mar 28, 2024, 4:00 PM
27.83
+0.89 (3.30%)
After-hours: Mar 28, 2024, 5:36 PM EDT

Rocket Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Net Income
-245.6-221.86-169.07-139.7-77.27-74.52-19.58-7.57-67.98-9.53
Upgrade
Depreciation & Amortization
7.16.275.376.250.430.330.20.070.050
Upgrade
Share-Based Compensation
39.4131.0129.2418.5713.3713.61.320.272.380.18
Upgrade
Other Operating Activities
4.186.4513.340.24-1.196.82.091.7348.14-0.39
Upgrade
Operating Cash Flow
-194.92-178.14-121.16-74.64-64.66-53.79-15.96-5.5-17.42-9.74
Upgrade
Capital Expenditures
-16.47-8.62-7.72-29.06-23.27-1.43-0.76-0.34-0.410
Upgrade
Acquisitions
042.7300076.350000
Upgrade
Change in Investments
-81.59-103.4326.57-67.53-15.74-79.8100-31.260
Upgrade
Other Investing Activities
------0.38----
Upgrade
Investing Cash Flow
-98.07-69.3318.85-96.59-39.01-5.27-0.76-0.34-31.680
Upgrade
Share Issuance / Repurchase
208.4155.2937.68283.84178.14153.500112.160
Upgrade
Debt Issued / Paid
000-0.24000-0.0115.20.56
Upgrade
Other Financing Activities
----0.61-0.34-25.410.03-1.840.01
Upgrade
Financing Cash Flow
208.4155.2937.68282.99177.79153.525.410.02125.520.57
Upgrade
Net Cash Flow
-84.58-92.18-64.63111.7674.1294.448.68-5.8276.42-9.18
Upgrade
Free Cash Flow
-211.39-186.76-128.88-103.7-87.93-55.22-16.72-5.84-17.83-9.74
Upgrade
Free Cash Flow Per Share
-2.52-2.74-2.04-1.87-1.79-1.40-2.46-0.85-3.89-38.20
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).